Close

Biotech Stocks Underperform on Political Concerns (IBB)

May 31, 2022 10:37 AM EDT

Biotechnology stocks declined 2% Tuesday amid concerns that renewed talks between Manchin and Schumer could eventually lead to a bill with drug price control provisions.

  • Johnson & Johnson (NYSE: JNJ) -2.2%
  • Bristol-Myers Squibb (NYSE: BMY) -2%
  • Eli Lilly & Co. (NYSE: LLY) -3.3%
  • Pfizer (NYSE: PFE) -2.8%
  • AbbVie (NYSE: ABBV) -1.3%
  • Amgen (NASDAQ: AMGN) -1.4%
  • Regeneron (NASDAQ: REGN) -4%
  • iShares Nasdaq Biotechnology (NASDAQ: IBB) declined 2%



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Politics, Rumors, Trader Talk